论文部分内容阅读
目的:探讨血小板制剂在临产前并发血小板减少孕妇中的应用效果。方法:根据孕妇产前血小板计数,对血小板计数小于(10~52)×109/L的患者,结合引起血小板减少的原因,分别在产前、产中和产后输注不同剂量的机采血小板。结果:7例患者通过输注血小板后,血小板计数都有不同程度的提高,均达到50×109/L以上,产中和产后出血量少,无意外情况发生。结论:妊娠并发血小板减少治疗的重点虽然是治疗病因,但为了防止分娩时大出血,输注血小板制剂,提升血小板数是有必要的。
Objective: To investigate the effect of platelet preparation in pregnant women with prethrombotic thrombocytopenia. Methods: According to the prenatal platelet count in pregnant women, different doses of platelet were infused in the patients with platelet count less than (10 ~ 52) × 109 / L in combination with the cause of thrombocytopenia. Results: After platelet transfusion in 7 patients, the platelet count increased to some extent, reaching more than 50 × 109 / L, with less postpartum hemorrhage and no postnatal bleeding. Conclusions: The focus of treatment for concurrent thrombocytopenia in pregnancy is the cause of treatment. However, in order to prevent bleeding during childbirth, platelet transfusion and platelet count increase are necessary.